
<!DOCTYPE html>
<html lang="en">
  <head>
    <!-- Google tag (gtag.js) -->
<script async src="https://www.googletagmanager.com/gtag/js?id=G-L3204W7RLL"></script>
<script>
  window.dataLayer = window.dataLayer || [];
  function gtag(){dataLayer.push(arguments);}
  gtag('js', new Date());

  gtag('config', 'G-L3204W7RLL');
</script>

<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js?client=ca-pub-7796629299242643"
     crossorigin="anonymous"></script>
     
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Farxiga For Ckd Without Diabetes</title>
    <meta name="description" content="Diabetes Healthcare is India's No.1 Repository for Diabetes related FAQs. Chat with the AI expert and clear your doubts about Diabetes.">
    <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@picocss/pico@1/css/pico.min.css">
<meta property="og:title" content="Diabetes Healthcare is India's No.1 Repository for Diabetes related FAQs. Chat with the AI expert and clear your doubts about Diabetes." />
<meta property="og:description" content="Diabetes Healthcare: Chat with Live AI expert to get your doubts cleared about Diabetes. Check out the most comprehensive information about Diabetes in the internet for free." />
<meta property="og:image" content="/thumbnail.png" />

<meta property="twitter:card" content="summary_large_image" />
<meta property="twitter:url" content="https://diabetes-healthcare.in" />
<meta property="twitter:title" content="Diabetes Healthcare is India's No.1 Repository for Diabetes related FAQs. Chat with the AI expert and clear your doubts about Diabetes." />
<meta property="twitter:description" content="Diabetes Healthcare: Chat with Live AI expert to get your doubts cleared about Diabetes. Check out the most comprehensive information about Diabetes in the internet for free." />
<meta property="twitter:image" content="/thumbnail.png" /> 
<meta name="robots" content="index, follow" />
<meta name="author" content="Diabetic Healthcare" />
<link rel="apple-touch-icon" sizes="180x180" href="/apple-touch-icon.png">
<link rel="icon" type="image/png" sizes="32x32" href="/favicon-32x32.png">
<link rel="icon" type="image/png" sizes="16x16" href="/favicon-16x16.png">
<link rel="manifest" href="/site.webmanifest">
<link rel="mask-icon" href="/mstile-150x150.png" color="#5bbad5">
<meta name="msapplication-TileColor" content="#da532c">
<meta name="theme-color" content="#ffffff">
<meta http-equiv="Content-Security-Policy" content="script-src 'none', object-src 'none'">

  </head>
  <body class="container">
    <article>
 <strong> Diabetes Healthcare </strong> </article>

 <nav aria-label="breadcrumb">
    <ul><strong>
        <li><a href="/">Home</a></li>
        <li><a href="/blog">Blog</a></li>
        <li><a href="https://app.diabetes-healthcare.in">Chat with Expert</a></li></strong>
      </ul>
    </nav>

    <h1>
       Farxiga For Ckd Without Diabetes
    </h1>
<p>Farxiga, also known as dapagliflozin, is a medication primarily used to treat type 2 diabetes. However, recent studies have shown that it may also be beneficial for patients with chronic kidney disease (CKD) who do not have diabetes. This is an exciting development in the field of nephrology, as CKD is a prevalent and serious condition that affects millions of people worldwide.</p>
<p>CKD is a progressive condition that occurs when the kidneys are damaged and cannot filter waste products from the blood effectively. Over time, this can lead to a buildup of toxins in the body and can increase the risk of other health complications, such as cardiovascular disease. Traditionally, treatment options for CKD have been limited, with the focus being on managing symptoms and slowing down the progression of the disease.</p>
<p>However, recent clinical trials have shown that Farxiga can significantly reduce the risk of kidney failure and cardiovascular events in patients with CKD, even in the absence of diabetes. The medication works by inhibiting the sodium-glucose cotransporter 2 (SGLT2) in the kidneys, which helps to remove excess glucose and sodium from the body through urine.</p>
<p>By reducing the workload on the kidneys and improving their function, Farxiga has the potential to slow down the progression of CKD and improve the overall health outcomes for patients. This is particularly significant for individuals who do not have diabetes, as they may not have access to other medications that are commonly used to treat CKD.</p>
<p>It is important to note that Farxiga is not currently approved by the FDA for the treatment of CKD without diabetes. However, the positive results from clinical trials have prompted further research and discussions among healthcare professionals about its potential use in this patient population.</p>
<p>In conclusion, Farxiga may hold promise as a treatment option for individuals with CKD who do not have diabetes. Further research is needed to fully understand its efficacy and safety in this patient population. Nonetheless, this development brings hope for improved outcomes and a better quality of life for those affected by CKD.</p>

  </body>

</html>